Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2026-01-10 @ 2:46 PM
Study NCT ID:
NCT00244933
Status:
COMPLETED
Last Update Posted:
2023-06-22
First Post:
2005-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-02
Start Date Type:
None
Primary Completion Date:
2008-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-25
First Submit QC Date:
None
Study First Post Date:
2005-10-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-01-12
Results First Submit QC Date:
None
Results First Post Date:
2015-02-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-22
Last Update Post Date:
2023-06-22
Last Update Post Date Type:
ACTUAL